PhoQ Mutations Promote Lipid A Modification and Polymyxin Resistance of Pseudomonas aeruginosa Found in Colistin-Treated Cystic Fibrosis Patients

Pseudomonas aeruginosa can develop resistance to polymyxin and other cationic antimicrobial peptides. Previous work has shown that mutations in the PmrAB and PhoPQ regulatory systems can confer low to moderate levels of polymyxin resistance (MICs of 8 to 64 mg/liter) in laboratory and clinical strai...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Miller, Amanda K., Brannon, Mark K., Stevens, Laurel, Johansen, Helle Krogh, Selgrade, Sara E., Miller, Samuel I., Høiby, Niels, Moskowitz, Samuel M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2011
Aiheet:
Mechanisms of Resistance
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3232818/
https://ncbi.nlm.nih.gov/pubmed/21968359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05391-11
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia